104 related articles for article (PubMed ID: 7503620)
1. [Calcium antagonists and primary prevention of coronary disease].
Rehnqvist N
Arch Mal Coeur Vaiss; 1995 Sep; 88 Spec No 4():13-6. PubMed ID: 7503620
[TBL] [Abstract][Full Text] [Related]
2. Effects of metoprolol vs verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm (APSIS).
Rehnqvist N; Hjemdahl P; Billing E; Björkander I; Eriksson SV; Forslund L; Held C; Näsman P; Wallén NH
Eur Heart J; 1996 Jan; 17(1):76-81. PubMed ID: 8682134
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implications of results from exercise testing in patients with chronic stable angina pectoris treated with metoprolol or verapamil. A report from the Angina Prognosis Study In Stockholm (APSIS).
Forslund L; Hjemdahl P; Held C; Björkander I; Eriksson SV; Brodin U; Rehnqvist N
Eur Heart J; 2000 Jun; 21(11):901-10. PubMed ID: 10806014
[TBL] [Abstract][Full Text] [Related]
4. Differential index: a simple time domain heart rate variability analysis with prognostic implications in stable angina pectoris.
Bjorkander I; Forslund L; Kahan T; Ericson M; Held C; Rehnqvist N; Hjemdahl P
Cardiology; 2008; 111(2):126-33. PubMed ID: 18376124
[TBL] [Abstract][Full Text] [Related]
5. Favourable long term prognosis in stable angina pectoris: an extended follow up of the angina prognosis study in Stockholm (APSIS).
Hjemdahl P; Eriksson SV; Held C; Forslund L; Näsman P; Rehnqvist N
Heart; 2006 Feb; 92(2):177-82. PubMed ID: 15951393
[TBL] [Abstract][Full Text] [Related]
6. Prognostic implications of renal dysfunction in patients with stable angina pectoris.
Almquist T; Forslund L; Rehnqvist N; Hjemdahl P
J Intern Med; 2006 Dec; 260(6):537-44. PubMed ID: 17116004
[TBL] [Abstract][Full Text] [Related]
7. Long-term stability of heart rate variability in chronic stable angina pectoris, and the impact of an acute myocardial infarction.
Björkander I; Forslund L; Ericson M; Rehnqvist N; Hjemdahl P; Kahan T
Clin Physiol Funct Imaging; 2009 May; 29(3):201-8. PubMed ID: 19254330
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular prognosis in relation to apolipoproteins and other lipid parameters in patients with stable angina pectoris treated with verapamil or metoprolol: results from the Angina Prognosis Study in Stockholm (APSIS).
Held C; Hjemdahl P; Rehnqvist N; Björkander I; Forslund L; Brodin U; Berglund L; Angelin B
Atherosclerosis; 1997 Nov; 135(1):109-18. PubMed ID: 9395279
[TBL] [Abstract][Full Text] [Related]
9. Effect of metoprolol on death and cardiac events during a 2-year period after coronary artery bypass grafting. The MACB Study Group.
Eur Heart J; 1995 Dec; 16(12):1825-32. PubMed ID: 8682014
[TBL] [Abstract][Full Text] [Related]
10. Verapamil in the long-term treatment of angina pectoris.
Raftos J
Clin Exp Pharmacol Physiol Suppl; 1982; 6():43-9. PubMed ID: 6811176
[TBL] [Abstract][Full Text] [Related]
11. The impact of diabetes or elevated fasting blood glucose on cardiovascular prognosis in patients with stable angina pectoris.
Held C; Björkander I; Forslund L; Rehnqvist N; Hjemdahl P
Diabet Med; 2005 Oct; 22(10):1326-33. PubMed ID: 16176191
[TBL] [Abstract][Full Text] [Related]
12. Fibrinolytic variables and cardiovascular prognosis in patients with stable angina pectoris treated with verapamil or metoprolol. Results from the Angina Prognosis study in Stockholm.
Held C; Hjemdahl P; Rehnqvist N; Wallén NH; Björkander I; Eriksson SV; Forslund L; Wiman B
Circulation; 1997 May; 95(10):2380-6. PubMed ID: 9170400
[TBL] [Abstract][Full Text] [Related]
13. Age-related changes of antianginal effects of verapamil in patients with stable effort angina. A medium term randomized double-blind placebo controlled trial.
Acanfora D; De Caprio L; Di Palma A; Lirato C; Parlati S; Furgi G; Guerra N; Odierna L; Nicolino A; Rengo F
G Ital Cardiol; 1993 May; 23(5):451-8. PubMed ID: 8339870
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris. Results from the APSIS study. The Angina Prognosis Study in Stockholm.
Held C; Hjemdahl P; Håkan Wallén N; Björkander I; Forslund L; Wiman B; Rehnqvist N
Atherosclerosis; 2000 Jan; 148(1):179-88. PubMed ID: 10580184
[TBL] [Abstract][Full Text] [Related]
15. Combination treatment in stable effort angina using trimetazidine and metoprolol: results of a randomized, double-blind, multicentre study (TRIMPOL II). TRIMetazidine in POLand.
Szwed H; Sadowski Z; Elikowski W; Koronkiewicz A; Mamcarz A; Orszulak W; Skibińska E; Szymczak K; Swiatek J; Winter M
Eur Heart J; 2001 Dec; 22(24):2267-74. PubMed ID: 11728147
[TBL] [Abstract][Full Text] [Related]
16. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.
Di Somma S; de Divitiis M; Bertocchi F; Carotenuto A; Cudemo G; Petitto M; Napodano M; de Divitiis O
Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181
[TBL] [Abstract][Full Text] [Related]
17. Abrupt change from propranolol to verapamil. Safety and feasibility in stable angina pectoris.
Winniford MD; Fulton KL; Hillis LD
Arch Intern Med; 1986 Apr; 146(4):795. PubMed ID: 3963962
[TBL] [Abstract][Full Text] [Related]
18. Platelet aggregability in vivo is attenuated by verapamil but not by metoprolol in patients with stable angina pectoris.
Wallén NH; Held C; Rehnqvist N; Hjemdahl P
Am J Cardiol; 1995 Jan; 75(1):1-6. PubMed ID: 7801853
[TBL] [Abstract][Full Text] [Related]
19. [Effectiveness of verapamil in the treatment of unstable angina at rest. Double-blind crossover studies in the coronary care unit].
Parodi O; Simonetti I; Maseri A; Distante A
Boll Soc Ital Cardiol; 1977; 22(8):1331-41. PubMed ID: 618268
[No Abstract] [Full Text] [Related]
20. Primary prevention in patients with coronary heart disease: the APSIS study.
Rehnqvist N; Hjemdahl P; Björkander I; Eriksson SV; Forslund L; Held C; Wallén H; Billing E
Cardiovasc Drugs Ther; 1995 Aug; 9 Suppl 3():493. PubMed ID: 8562465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
